|
|||||||
|
|||||||
Probiotic scientific research and results of studies.There is just so much litrature and scientific study research on the benefits of probiotic and prebiotic it would be impossible to put on just one page. So as well as giving links to Medical publications, we are giving links to other sites which cover scientific study results. From PUBMED Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for
treating infectious diarrhoea. Cochrane Database Syst Rev 2004;(2):CD003048.
PMID 15106189 From the Obtibac Probiotics site Williams E, et al (2008) Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment Pharmacol Ther. September 10 2008 Kocian, J. (1996). Further Possibilities in the Treatment of Lactose Intolerance: Lactobacilli. Prakticky Lekar (General Practitioner). Vol. 74. pp. 212 214 Hill, M. J. (1997) Intestinal flora and endogenous vitamin synthesis. European Journal of Cancer Prevention; Vol. 6 Suppl. 1 pp. S43 5 Guarner, F. & Malagelada, J. R. (2003) Gut flora in health and disease. Lancet; Vol. 8 pp. 512 9 Gibson, G.R. & Wang, X. (1994) Regulatory Effects of Bifidobacteria on the growth of other colonic bacteria. The Journal of Applied Bacteriology. Oct;77(4):412-20. Drisko, J. A, et al. (2003) Probiotics in health maintenance and disease prevention. Alternative Medicine Review; Vol. 8 (2) pp.143 - 55. Kimoto, H. et al (2004) New Lactococcus strain with immunomodulatory activity: enhancement of Th1-type immune response. Microbiology and Immunology; Vol. 48 (2) pp.75 82 Kumar et al. (2005) Beneficial effects of probiotics and prebiotics on human health; Pharmazie Vol. 60 (3) pp.163 71 Saavedra, J. & Tschernia, A. (2002) Human studies with probiotics and prebiotics: clinical implications. British Journal of Nutrition, Volume 87, Supplement s2, 1 May 2002, pp. 241-246(6) Gibson, G. R. et al (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology. Apr;108(4):975-82. Diop, L. et al. (2007) Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomised trial. Nutrition Research 28. Clinical Trials on Lactobacillus acidophilus NCFM® Sui, J et al. (2002) 16S ribosomal DNA analysis of the faecal lactobacilli composition of human subjects consuming a probiotic strain Lactobacillus acidophilus NCFM®. J Appl Microbiol 93:907-912. Ouwehand, AC et al. (2009) Influence of a combination of Lactobacillus acidophilus NCFM® and lactitol on healthy elderly: intestinal and immune parameters. British Journal of Nutrition, Vol. 101, pp. 367-375 Engelbrektson, AL et al. (2005) Analysis of treatment effects on the microbial ecology of the gastrointestinal tract. PhD Thesis, California Polytechnic State University, San Luis Obispo, USA. Varcoe, J et al. (2002) Variable response to exogenous Lactobacillus acidophilus NCFM® consumed in different delivery vehicles. J Appl Microbiol 93:900-906. Crowell, DC. (1998) Microbial analysis of human intestinal flora after feeding Lactobacillus acidophilus. M.S. Thesis, North Carolina State Univ, Raleigh. Gilliland, SW et al. (1978) Influence of consuming nonfermented milk containing Lactobacillus acidophilus on fecal flora of healthy males. J Dairy Sci 61:1-10. Gilliland, SE et al. (1975) Detection of Lactobacillus acidophilus in feces of humans, pigs, and chickens. Appl Microbiol; 30(4):541-545. Clinical Trials on Lactobacillus acidophilus NCFM® with Bifidobacterium
lactis Bl-04 Clinical Trials on Lactobacillus acidophilus NCFM® with Bifidobacterium
lactis Bi-07 Ringel, Y. et al. (2008) Probiotic bacteria Lactobacillus acidophilus NCFM® and Bifidobacterium lactis Bi-07 improve symptoms of bloating in patients with function bowel disorders (FBD). Gastoenterology; Vol 134(4 Suppl. 1):A549 Clinical Trials on Bifidobacterium lactis Bl-04 Drisko, J. A. et al. (2003) Probiotics in Health Maintenance and Disease Prevention. Alternative Medicine Review; Vol. 8 (2) pp. 143 - 156 Hill, M. J. (1997) Intestinal flora and endogenous vitamin synthesis. European Journal of Cancer Prevention; Vol. 6 Suppl. 1 pp. S43 5 Famularo, G. et al (2005) Probiotic lactobacilli: an innovative tool to correct the malabsorption syndrome of vegetarians? Medical Hypotheses; Vol. 65 (6) pp.1132 5 Hebuterne, X. (2003) Gut changes attributed to ageing: effects on intestinal microflora. Current Opinion in Clinical Nutrition and Metabolic Care; Vol. 6 (1) pp. 49 54. Hughes, D. A. (1999) Effects of dietary antioxidants on the immune function of middle-aged adults. Proceedings of Nutrition Society; Vol. 58 (1) pp. 79 - 84 Forchielli, M. L. & Walker, W. A. (2005) The role of gut-associated lymphoid tissues and mucosal defence. British Journal of Nutrition; Vol. 93 Suppl. 1 pp. S41 8 Fasano, A. & Shea-Donohue, T. (2005) Mechanisms of disease: the
role of intestinal barrier function in the pathogenesis of gastrointestinal
autoimmune diseases. Nature Clinical Practice Gastroenterology &
Hepatology; Vol. 2 (9) pp.416 422. Clinical Research on Probiotics, Prebiotics and Bloating Paineau, D. (2007) Regular consumption of short-chain fructo-oligosachharides improves digestive comfort with minor functional bowel disorders. Br. J. Nutr. Aug 13:1-8 [Epub ahead of print] Colecchia, A. (2006) Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Minerva Gastroenterol. Dietol. 2006. 52:349-358 Tokunaga, T. (1993) Effects of fructooligosachharides (FOS) intake on the intestinal microflora and defecation in healthy volunteers. Bifidus. (6) 143-150. Houghton, L. A. & Whorwell, P. J. (2005) Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders. Neurogastroenterology & Motility. Vol. 17 pp. 500 511 Zar, S, et al. (2002) Review Article: bloating in functional bowel disorders. Alimentary Pharmacology and Therapeutics. Vol. 16 pp. 1867 - 1876 Kumar, D. et al. (2005) Beneficial effects of probiotics and prebiotics on human health; Pharmazie Vol. 60 (3) pp.163 171 Gibson, G. R. et al (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology. Apr;108(4):975-82. Clinical Research on probiotics and antibiotics Jirapinyo, P. et al. (2002) Prevention of antibiotic-associated diarrhoea in infants by probiotics. J Med Assoc Thai 2002; 85 (Suppl 2): S739-S42. Firmesse, O. et al (2005). Quantification after transit in human digestive tract of For those on anti biotics (Lactobacillus Rhamnosus Rosell 11 & Lactobacillus Acidophilus Rosell 52) consumed in a food supplement. National Institute of Agronomic Research. Presented at Rome Conference on probiotics. Dr Benes, Z. et al. (2006) Lacidofil (Lactobacillus Rosell 52 & Lactobacillus Rosell 11) alleviates symptoms of IBS. Nutrafoods, Vol. 5 pp. 20 -27 Kocian, J. (1996). Further Possibilities in the Treatment of Lactose Intolerance: Lactobacilli. Prakticky Lekar (General Practitioner). Vol. 74. pp. 212 214 Vanderhoof, J.A. et al. (1999) Lactobacillus rhamnosus (GG) in the prevention of antibiotic-associated diarrhea in children. J Pediatrics 1999; 135: 564-8. Arvola, T. et al. (1999) Prophylactic Lactobacillus rhamnosus (GG) reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104(5): e64. Tlaskal, P. et al (1995) For those on antibiotics (Lactobacillus acidophilus & rhamnosus) in the Treatment of Children with Gastrointestinal Tract Illness; Cesko-Slovenska pediatrie. Vol. 51 pp. 615-619 Wallace, T. D. et al (2003). 'Interactions of Lactic Acid Bacteria with Human Intestinal Epithelial Cells: Effects on Cytokine Production'. Journal of Food Protection. Vol. 66 Iss. 3 pp. 466 472 Ziemniak, W. (2006). Efficacy of Helicobacter Pylori eradication
taking into account its resistance to anitbiotics. Journal of Physiology
and Pharmacology. Supp 3, p. 123-141 Clinical Research on Saccharomyces boulardii and diarrhoea Hochter, W. et al (1990) Saccharomyces boulardii in acute adult diarrhea. Efficacy and tolerance of treatment. Munchener Medizinische Wochenschrift; Vol. 132 (12) pp. 188-192. Cetina-Sauri, G. & Basto, S. (1994) Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea. Annales de Pediatrie; Vol. 41 (6) pp. 397-400. Kurugol, Z. & Koturoglu, G. (2005) Effects of Saccharomyces boulardii in children with acute diarrhea. Acta Paediatrica; Vol. 94 pp. 44-47. Maupas, J.L. et al. (1983) Treatment of Irritable Bowel Syndrome (IBS) Double Blind Trial of Saccharomyces boulardii. Medecine Chirurgie Digestives. Vol. 12 (1) pp. 77 79. Kotowska, M. et al. (2005) Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Alimentary Pharmacology & Therapeutics 21 (5), 583590 Erdeve, O. et al. (2004) 'The probiotic effect of S.boulardii in a pediatric age group' Journal of Trop Pediatr. Aug;50(4) pp.234-6 D'Souza, A. et al. (2002) Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. Care of the Elderly Section, Faculty of Medicine, Imperial College School of Medicine, Hammersmith Hospital, London. BMJ 2002;324:1361 ( 8 June ) Kirchhelle, A. et al. (1996) Treatment of persistent diarrhoea with Saccharomyces boulardii in returning travellers. Results of a prospective study; Fortschr Med; Vol. 114 (11) pp. 136-140 Grandy, G. et al. (2010) Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children; BMC Infectious Diseases, Vol. 10 pp. 253 Clinical Research on Saccharomyces boulardii and Candida Jawhara, S. & Poulain, D. (2007) Saccharomyces boulardii decreases inflammation and intestinal colonisation by Candida albicans in a mouse model of chemically-induced colitis. Medical Mycology, Vol. 45. Issue 8. pp 691 - 700. Berg, R. et al. (1993) Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomcyes boulardii. J Infect Dis. 1993,Nov;168(5):1314-8. Murzyn, et al. (2010) Capric Acid Secreted by S. boulardii Inhibits C. Albicans. August 2010, Plos One, Vol. 5. Issue 8. Clinical Research on Saccharomyces boulardii and Clostridium difficile
disease Surawicz, C.M. et al (2000) The Search for a Better Treatment for Recurrent Clostridium difficile Disease: Use of High-Dose Vancomycin Combined with Saccharomyces boulardii. Clinical Infectious Diseases. Vol. 31 pp. 1012 1017 Buts, J. et al. (1993) Saccharomyces boulardii for Clostridium difficile-Associated Enteropathies in Infants. Journal of Pediatric Gastroenterology and Nutrition. Vol. 16 pp. 419 425 Surawicz, C.M. et al. (1989) Treatment of Recurrent Clostridium difficile Colitis with Vancomycin and Saccharomyces boulardii. The American Journal of Gastroenterology. Vol. 85 (10) Surawicz, C.M. (2003) Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Practice & Research Clinical Gastroenterology. Vol. 17 (5) pp. 775 783 Castagliuolo, I. et al. (1999) Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun. 67(I): 302 - 307. Pothoulakis, C. et al. (1993) Saccharomyces boulardii inhibits Clostridium difficile toxin: A binding and enterotoxicity in rat ileum. Gastroenterology: 104(4): 1108 - 1115. Tung, J.M et al. (2010) Prevention of Clostridium difficile with Saccharomyces boulardii: A systematic review; Canadian Journal of Gastroenterology, Vol. 23(12) pp. 817-821 Clinical Research on Saccharomyces boulardii and Inflammatory Bowel
Disease Guslandi, M. et al. (2003) A pilot trial of Saccharomyces boulardii
in ulcerative colitis. European Journal of Gastroenterology &
Hepatology. Vol. 15 pp. 697 698. Clinical Research on probiotics and travelling Gibson, G.R. & Wang, X. (1994) Regulatory Effects of Bifidobacteria on the growth of other colonic bacteria. The Journal of Applied Bacteriology. Oct;77(4):412-20. Kollaritsch, H. H. et al (1993) Prevention of travellers diarrhoea: Comparison of different non-antibiotic preparations. Results of a placebo-controlled double-blind study; Fortschr Med; Vol. 111 pp. 152-156 Kirchhelle, A. et al. (1996) Treatment of persistent diarrhoea with Saccharomyces Boulardii in returning travellers. Results of a prospective study; Fortschr Med; Vol. 114 (11) pp. 136-140 Wallace, T. D. et al (2003). Interactions of Lactic Acid Bacteria with Human Intestinal Epithelial Cells: Effects on Cytokine Production. Journal of Food Protection. Vol. 66 Iss. 3 pp. 466 472 Hilton, E. et al (1997) Efficacy of Lactobacillus rhamnosus (GG) as a Diarrheal Preventive in Travelers. Journal of Travel Medicine 4 (1), 4143 Teitelbaum, J. E. (2005) Probiotics and the Treatment of Infectious
Diarrhea. The Pediatric Infectious Disease Journal 24:3, 267 Research on the probiotic strain in For maintaining regularity Pitkala, K.H et al. (2007) Fermented cereal with specific bifidobacteria normalizes bowel movements in elderly nursing home residents. A randomized, controlled trial. Journal of Nutritional Health and Aging; 11(4): pp.305-311. Nishida, S. et al. (2004) Effect of Yogurt Containing Bifidobacterium lactis BB-12® on Improvement of Defecation and Fecal Microflora of Healthy Female Adults. Milk Science; 53(2): pp. 71-80 Murakami, T. et al (2006) Safety and effect of yoghurt containing Bifidobacterium lactis BB-12® on improvement of defecation and faecal microflora in healthy volunteers. Journal of Nutritional Food; 9 pp. 15-26 Uchida et al. (2005) Effect of fermented milk containing Bifidobacterium lactis BB-12® on stool frequency, defecation, fecal microbiota and safety of excessive ingestion in healthy female students. Journal of Nutritional Food. 8(1): pp.39-51 Rizzardini, G. et al (2011) Evaluation of the immune benefits of two probiotic strains Bifidobacterium lactis BB-12® and Lactobacillus casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition Clinical trials on all probiotic strains in For your child's health Cazzola, M. et al. (2010) Immunomodulatory impact of synbiotic in TH1 and TH2 models of infection; Therapeutic Advances in Respiratory Disease 0(0) pp. 1-13 Clinical Research on probiotics and infants & children Marschan, E. et al. (2008). Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation; Clinical and Experimental Allergy the Journal of the British Society of Allergy and Clinical Immunology; Feb 11 Rautava, S. et al (2002). Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. Journal of Allergy and Clinical Immunology, Jan Vol. 109 (1), pp. 119-121 Rosenfeldt. V, et al (2002) Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr Infect Dis J;21 :411 416 Knol J. et al. (2005) Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. Journal of pediatric gastroenterology and nutrition. Jan; Vol. 40 (1) pp.36 - 42 Saavedra, J.M. et al. (1994) Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. The Lancet. Oct 15;344(8929):1046-9. Saavedra, J.M, et al. (1989) Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety: American Journal of Clinical Nutrition: Vol. 79. pp. 261-267 Fukushima, Y. et al (1998). Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. International Journal of Food Microbiology. Vol. 42 (1-2), pp. 39 - 44 Zajewska, H. & Mrukowicz, J.Z. (2001) Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr;33(suppl 2) :S17 S25) Langhendries, J.P et al. (1995) Effect of fermented infant formula
containing viable bifidobacteria on the fecal flora composition and
pH of healthy full-term infants: J Pediatr Gastroenterol Nutr, 21,
2, 177081
© Probiotic.co.uk. 2012 - Please view our legal disclaimer and Cookies Policy Probiotic Scientific research and study referrence |